About Dosch Pharmaceuticals Private Limited
Data last updated:
Dosch Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 April 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74110MH1995PTC087284. Its GSTIN is 27AAICD3731G1ZR (Maharashtra).
The company has an authorised share capital of ₹45.65 Cr and a paid-up capital of ₹45.64 Cr. It was formerly known as Dosch Pharmatech Private Limited and Non Destructive Engineering Company Private Limited. It is led by directors including Ashay Sanjay Doshi and Sanjay Kanaiyalal Doshi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 15 C Laxmi Indl Estate New Link Road Andheri West, Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹229.86 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹35.09 Cr (net margin 15.3%) and EBITDA of ₹47.46 Cr (EBITDA margin 20.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 27% over five years.
The company is associated with 1 brand: Dosch Pharmaceuticals. As per MCA filings, the company has open charges of ₹32.65 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dosch.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address15 C Laxmi Indl Estate New Link Road Andheri West, Mumbai, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dosch Pharmaceuticals Private Limited
The main business activity of Dosch Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dosch Pharmaceuticals Private Limited FY 2024 filings available
Dosch Pharmaceuticals Private Limited reported revenue of ₹229.86 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dosch Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 3% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dosch Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹47.46 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹35.09 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dosch Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 15.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dosch Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dosch Pharmaceuticals Private Limited
Dosch Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stallion Laboratories Pvt Ltd | ₹234.32 Cr (FY 2024) | •••• | •••• | 25.0% | •••• | Ahmedabad, Gujarat, India |
| Ferring Pharmaceuticals Private Limited | ₹233.5 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Emil Pharmaceutical Industries Private Limited | ₹232.55 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Axa Parenterals Limited | ₹231.46 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Delhi, India |
| Medwise Overseas Private Limited | ₹230.52 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Ahmedabad, Gujarat, India |
| Dosch Pharmaceuticals Private Limited this company | ₹229.86 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Ahlcon Parenterals (India) Limited | ₹229.53 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | New Delhi, Delhi, India |
| Medopharm Private Limited | ₹229.32 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Chennai, Tamil Nadu, India |
| Hindustan Laboratories Limited | ₹227.37 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Mumbai, Maharashtra, India |
| Aura Pharmaceuticals Private Limited | ₹223.55 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Dosch Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dosch Pharmaceuticals Private Limited
Dosch Pharmaceuticals Private Limited is audited by ARUN M AGARWAL & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARUN M AGARWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dosch Pharmaceuticals Private Limited
Dosch Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashay Sanjay Doshi Also directs: Sthir Consulting LLP, Pref Asset Management Ifsc LLP | Director | 15 Oct 2017 | 8 Years 11 Months | Current |
| Sanjay Kanaiyalal Doshi | Director | 15 Oct 2017 | 8 Years 11 Months | Current |
| Prachi Sanjay Doshi | Director | 15 Mar 2021 | 5 Years 6 Months | Current |
Ownership and Shareholding of Dosch Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dosch Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jul 2023 | Others | ₹3.35 Cr | Open |
| 26 May 2023 | Others | ₹2.3 Cr | Open |
| 24 Nov 2015 | Others | ₹27 Cr | Open |
Total charge records: 3 View all charges
Associated Brands with Dosch Pharmaceuticals Private Limited
Dosch Pharmaceuticals operates one associated brand: Dosch Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of Veterinary Pharmaceuticals and Exporter of Bulk Drugs and Formulations. | dosch.com |
Employees and EPFO Compliance at Dosch Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Dosch Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Name History of Dosch Pharmaceuticals Private Limited
Dosch Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Dosch Pharmatech Private Limited, and Non Destructive Engineering Company Private Limited. The current legal name is Dosch Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Dosch Pharmaceuticals Private Limited | Current |
| Dosch Pharmatech Private Limited | Previous |
| Non Destructive Engineering Company Private Limited | Previous |
CIN History of Dosch Pharmaceuticals Private Limited
Dosch Pharmaceuticals has one previous CIN (Corporate Identification Number): U74210MH1995PTC087284. The current CIN is U74110MH1995PTC087284, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110MH1995PTC087284 | Current |
| U74210MH1995PTC087284 | Previous |
Recent Activity on Dosch Pharmaceuticals Private Limited
Dosch Pharmaceuticals Private Limited has 9 board changes on record since 2017: 3 appointments and 6 cessations. The latest: Prachi Sanjay Doshi ceased to be Additional Director on 30 Nov 2021.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Dosch Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dosch Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dosch Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dosch Pharmaceuticals Private Limited
Dosch Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICD3731G1ZR | Maharashtra | Active | 25 Mar 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dosch Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dosch Pharmaceuticals Private Limited
Dosch Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 April 1995 (31+ years old) and is registered under CIN U74110MH1995PTC087284.
Dosch Pharmaceuticals reported revenue of ₹229.86 Cr for FY 2025 (up 3% YoY).
Dosch Pharmaceuticals has 3 current directors:
- Ashay Sanjay Doshi - Director
- Sanjay Kanaiyalal Doshi - Director
- Prachi Sanjay Doshi - Director
Dosch Pharmaceuticals reported a net profit of ₹35.09 Cr (net margin 15.3%) and EBITDA of ₹47.46 Cr (EBITDA margin 20.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dosch Pharmaceuticals is 14% over three years and 27% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dosch Pharmaceuticals is 27AAICD3731G1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dosch Pharmaceuticals is U74110MH1995PTC087284. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dosch Pharmaceuticals was incorporated on 07 April 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dosch Pharmaceuticals by revenue are Stallion Laboratories Pvt Ltd, Ferring Pharmaceuticals Private Limited, Emil Pharmaceutical Industries Private Limited, Axa Parenterals Limited, Medwise Overseas Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Prachi Sanjay Doshi ceased to be Additional Director on 30 Nov 2021. Nikhil Ramesh Parikh ceased to be Director on 15 Mar 2021. Prachi Sanjay Doshi was appointed as Director on 15 Mar 2021. Dosch Pharmaceuticals has 9 board changes on record in total.
Dosch Pharmaceuticals can be reached through the website dosch.com. Its registered office is in Mumbai, Maharashtra, India.